After months of increasingly rancorous debate, the House finally approved legislation on Mar. 21, 2010, that makes significant changes in the nation's healthcare system.
Mar 22, 2010
By:
Jill Wechsler
After months of increasingly rancorous debate, the House finally approved legislation on Mar. 21, 2010, that makes significant changes in the nation's healthcare system.
|
FDA modernizes information systems, expands access to drug safety and use information.
Mar 2, 2010
By:
Jill Wechsler
FDA modernizes information systems, expands access to drug safety and use information.
|
Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.
Feb 2, 2010
By:
Jill Wechsler
Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.
|
Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.
Jan 2, 2010
By:
Jill Wechsler
Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.
|
|
Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.
Dec 2, 2009
By:
Jill Wechsler
Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.
|
The heightened focus on risk raises concerns about delays in approving new drugs.
Nov 2, 2009
By:
Jill Wechsler
The heightened focus on risk raises concerns about delays in approving new drugs.
|
Strict enforcement, new rules, and organizational changes signal an activist tone.
Oct 2, 2009
By:
Jill Wechsler
Strict enforcement, new rules, and organizational changes signal an activist tone.
|
Health crises generate support for new vaccines and treatments for diseases found in developing nations.
Sep 2, 2009
By:
Jill Wechsler
Health crises generate support for new vaccines and treatments for diseases found in developing nations.
|
Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.
Aug 2, 2009
By:
Jill Wechsler
Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.
|
|
